These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26973383)

  • 1. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?
    García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Villarreal-Pérez JZ; Maldonado-Garza HJ
    World J Gastroenterol; 2016 Mar; 22(10):2869-74. PubMed ID: 26973383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatogenous diabetes. Current views of an ancient problem.
    García-Compean D; Jaquez-Quintana JO; Maldonado-Garza H
    Ann Hepatol; 2009; 8(1):13-20. PubMed ID: 19221528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
    Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G
    Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features].
    Kalmykova ZA; Kononenko IV; Mayorov AY
    Ter Arkh; 2019 Dec; 91(12):115-121. PubMed ID: 32598598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of hepatogenous diabetes in liver cirrhosis.
    Holstein A; Hinze S; Thiessen E; Plaschke A; Egberts EH
    J Gastroenterol Hepatol; 2002 Jun; 17(6):677-81. PubMed ID: 12100613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
    Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does telaprevir possess a direct antidiabetic effect?
    Tallón de Lara P; Himschoot T; Frossard JL; Negro F
    Liver Int; 2014 Jul; 34(6):967-9. PubMed ID: 24329983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
    Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
    Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Association with Liver Diseases: An Overview for Clinicians.
    Hamed AE; Elwan N; Naguib M; Elwakil R; Esmat G; El Kassas M; Abd-Elsalam S; Moussa S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(3):274-280. PubMed ID: 30444204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.
    Desbois AC; Cacoub P
    World J Gastroenterol; 2017 Mar; 23(9):1697-1711. PubMed ID: 28321170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.
    Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
    J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.
    García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Villarreal-Pérez JZ; Maldonado-Garza HJ
    Dig Dis Sci; 2016 Feb; 61(2):371-80. PubMed ID: 26462490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of diabetes mellitus of patients with chronic liver disease.
    García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Maldonado-Garza HJ; Villarreal-Pérez JZ
    Ann Hepatol; 2015; 14(6):780-8. PubMed ID: 26436350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatogenous diabetes - diagnostics and treatment].
    Gundling F; Schumm-Draeger PM; Schepp W
    Z Gastroenterol; 2009 May; 47(5):436-45. PubMed ID: 19418413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.
    Saeed MJ; Olsen MA; Powderly WG; Presti RM
    J Clin Gastroenterol; 2017 Jan; 51(1):70-76. PubMed ID: 27306942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.